Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial

BACKGROUND: Genital infection with herpes simplex virus type 2 (HSV-2) is common and increases risk of human immunodeficiency virus (HIV) transmission and acquisition. Pericoital use of tenofovir (TFV) gel provided protection from HSV-2 acquisition in the CAPRISA 004 study. METHODS: We measured esti...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Infect Dis
Hlavní autoři: Marrazzo, Jeanne M, Rabe, Lorna, Kelly, Cliff, Richardson, Barbra, Deal, Carolyn, Schwartz, Jill L, Chirenje, Z M, Piper, Jeanna, Morrow, Rhoda Ashley, Hendrix, Craig W, Marzinke, Mark A, Hillier, Sharon L
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Major Articles and Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534189/
https://ncbi.nlm.nih.gov/pubmed/30753642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz045
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky